F
N+ Score53
Joint & BoneServing: 1 Vegetarian Capsule(s)Type: Non-Nutrient/Non-Botanical

Lipo CaAKG by Renue By Science is a non-nutrient/non-botanical supplement categorized under Joint & Bone, though Calcium Alpha-Ketoglutarate (CaAKG) is commonly explored for its potential roles in metabolism and cellular health. Each one-capsule serving provides 300mg of Calcium Alpha-Ketoglutarate. The product received an N+ Score of 53, resulting in an 'F' grade, placing it in the below-average tier according to our assessment. Despite 100% label transparency, allowing full disclosure of the ingredient and its dosage, the product does not contain ingredients at clinically studied doses for its stated category, nor are there specific recognized clinical dosages for CaAKG in this context. Its low scores for ingredient adequacy and formula completeness suggest that the dosage or overall formulation may not meet robust scientific standards. This product may appeal to individuals interested in exploring CaAKG, but its N+ Score indicates potential areas for improvement in formulation based on current research.

About This Product

Lipo CaAKG by Renue By Science is a joint & bone supplement containing 1 active ingredients. It has earned an N+ Score of 53/100 (Grade F).

N+ Score Breakdown

Ingredient Adequacy50/100

Are key ingredients present at clinically effective doses based on research?

Formula Completeness25/100

Does the product include all expected ingredients for its supplement category?

Label Transparency100/100

Are individual ingredient amounts clearly disclosed without proprietary blends?

Ingredient Diversity44/100

Does the formula include a breadth of beneficial compounds from multiple pathways?

Strengths

  • +Fully transparent label with individual ingredient amounts disclosed

Weaknesses

  • Missing several expected ingredients for its category

Ingredient Analysis (1 ingredients)

IngredientAmountDose Adequacy
Calcium Alpha-Ketoglutarate300.000 mgN/A

Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.